Terms: = Lung cancer AND MUC16, CA125, CA-125 AND Diagnosis
184 results:
1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
2. Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer.
Wang Y; Ouyang S; Liu M; Si Q; Zhang X; Zhang X; Li J; Wang P; Ye H; Shi J; Song C; Wang K; Dai L
BMC Cancer; 2024 Mar; 24(1):283. PubMed ID: 38431566
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma.
Li X; Chen K; Li J; Tang X; Ruan H; Guan M
Front Immunol; 2024; 15():1339914. PubMed ID: 38304432
[TBL] [Abstract] [Full Text] [Related]
4. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
Trulson I; Klawonn F; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
[TBL] [Abstract] [Full Text] [Related]
5. IR808@MnO nano-near infrared fluorescent dye's diagnostic value for malignant pleural effusion.
Wang X; Yan X; Zhang Z; Xu C; Du F; Xie Y; Yin X; Lei Z; Jiang Y; Yang W; Zhou X; Wang Y
Respir Res; 2024 Jan; 25(1):22. PubMed ID: 38195540
[TBL] [Abstract] [Full Text] [Related]
6. Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing lung Adenocarcinoma and Benign Pulmonary Nodules.
Zhang X; Ji L; Liu M; Li J; Sun H; Liang F; Zhao Y; Wang Z; Yang T; Wang Y; Si Q; Du R; Dai L; Ouyang S
J Proteome Res; 2024 Jan; 23(1):277-288. PubMed ID: 38085828
[TBL] [Abstract] [Full Text] [Related]
7. [Diagnostic values of conventional tumor markers and their combination with chest CT for patients with stageⅠA lung cancer].
Peng Q; Wu N; Huang Y; Zhao SJ; Tang W; Liang M; Ran YL; Xiao T; Yang L; Liang X
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):934-941. PubMed ID: 37968078
[No Abstract] [Full Text] [Related]
8. The blood proteome of imminent lung cancer diagnosis.
Lung Cancer Cohort Consortium (LC3)
Nat Commun; 2023 Jun; 14(1):3042. PubMed ID: 37264016
[TBL] [Abstract] [Full Text] [Related]
9. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
10. Clinical role of serum tumor markers SCC, NSE, CA 125, CA 19-9, and CYFRA 21-1 in patients with lung cancer.
Sun A
Lab Med; 2023 Nov; 54(6):638-645. PubMed ID: 37052517
[TBL] [Abstract] [Full Text] [Related]
11. Genetic analysis of familial predisposition in the pathogenesis of malignant pleural mesothelioma.
Akarsu M; Ak G; Dündar E; Metintaş M
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7767-7778. PubMed ID: 37027032
[TBL] [Abstract] [Full Text] [Related]
12. A case of malignant peritoneal mesothelioma with a Fitz-Hugh-Curtis syndrome-like imaging finding.
Iwadare T; Kimura T; Nagata Y; Suzuki H; Kunimoto H; Kitabatake H; Seki A; Ochi Y; Hara E; Umemura T
Clin J Gastroenterol; 2023 Jun; 16(3):372-376. PubMed ID: 36781827
[TBL] [Abstract] [Full Text] [Related]
13. Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer.
Visser E; Genet SAAM; de Kock RPPA; van den Borne BEEM; Youssef-El Soud M; Belderbos HNA; Stege G; de Saegher MEA; van 't Westeinde SC; Brunsveld L; Broeren MAC; van de Kerkhof D; Deiman BALM; Eduati F; Scharnhorst V
Lung Cancer; 2023 Apr; 178():28-36. PubMed ID: 36773458
[TBL] [Abstract] [Full Text] [Related]
14. Combination of serum ACSL4 levels and low-dose 256-slice spiral CT exhibits the potential in the early screening of lung cancer.
Yu W; Wang L; Liu S; Liu Y; Wang S; Sun X
Medicine (Baltimore); 2023 Feb; 102(5):e32733. PubMed ID: 36749237
[TBL] [Abstract] [Full Text] [Related]
15. Increased levels of N6-methyladenosine in peripheral blood RNA: a perspective diagnostic biomarker and therapeutic target for non-small cell lung cancer.
Yin H; Hong H; Yin P; Lu W; Niu S; Chen X; Xia Y; Jiang P; Huang Z
Clin Chem Lab Med; 2023 Feb; 61(3):473-484. PubMed ID: 36542027
[TBL] [Abstract] [Full Text] [Related]
16. A case report of anterior mediastinal signet ring cell carcinoma.
Liu S; Zhao A; Mao M
Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
[TBL] [Abstract] [Full Text] [Related]
17. Serum Markers ca125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of lung cancer in High-Risk Populations.
Li G; Zhang H; Zhang L; Liu H; Li S; Wang Y; Deng X
Biomed Res Int; 2022; 2022():1394042. PubMed ID: 36299704
[TBL] [Abstract] [Full Text] [Related]
18. Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules.
Ma G; Yang D; Li Y; Li M; Li J; Fu J; Peng Z
Thorac Cancer; 2022 Dec; 13(23):3393-3401. PubMed ID: 36284506
[TBL] [Abstract] [Full Text] [Related]
19. [muc16: The Novel Target for Tumor Therapy].
Gao R; Lou N; Han X; Shi Y
Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):452-459. PubMed ID: 35899441
[TBL] [Abstract] [Full Text] [Related]
20. Multivariate Analysis on Development of lung Adenocarcinoma Lesion from Solitary Pulmonary Nodule.
Yu L; Zhang B; Zou H; Shi Y; Cheng L; Zhang Y; Zhen H
Contrast Media Mol Imaging; 2022; 2022():8330111. PubMed ID: 35795880
[TBL] [Abstract] [Full Text] [Related]
[Next]